The epidemiology of Haemophilus influenzae in healthy carriers and infected in Iceland following the introduction of Protein D conjugated vaccine

Introduction: Haemophilus influenzae is part of the normal flora of the nasopharynx but can cause a variety of infections, especially in young children and patients with underlying diseases. H. influenzae can express a polysaccharide capsule, six serotypes (a-f) have been identified. Strains without...

Full description

Bibliographic Details
Main Author: Sandra Berglind Tómasdóttir 1994-
Other Authors: Háskóli Íslands
Format: Thesis
Language:English
Published: 2019
Subjects:
Online Access:http://hdl.handle.net/1946/33427
_version_ 1821551718491488256
author Sandra Berglind Tómasdóttir 1994-
author2 Háskóli Íslands
author_facet Sandra Berglind Tómasdóttir 1994-
author_sort Sandra Berglind Tómasdóttir 1994-
collection Skemman (Iceland)
description Introduction: Haemophilus influenzae is part of the normal flora of the nasopharynx but can cause a variety of infections, especially in young children and patients with underlying diseases. H. influenzae can express a polysaccharide capsule, six serotypes (a-f) have been identified. Strains without a capsule are called Non-Typeable H. influenzae (NTHi). Antibiotic resistance in H. influenzae has increased for the last decade, especially because of penicillin-binding protein 3 (PBP3) modifications. In 2011 a 10-valent conjugated pneumococcal vaccine (PHiD-CV) was introduced in Iceland, which uses protein D (PD) derived from NTHi as a conjugate. PD is encoded by the hpd gene and is in most H. influenzae. By using PD as a conjugate there is a possibility that the vaccine could provide protection against H. influenzae infections. Aims: The aims of this study were to continue to assess the effects of the vaccination on carriage rate of H. influenzae among healthy children, the prevalence of the hpd gene and each serotype of H. influenzae both in carriage isolates and in clinical samples. Furthermore, to assess the effects on the antimicrobial susceptibility pattern of H. influenzae. Material and methods: Nasopharyngeal samples were obtained from healthy children attending 15 DCCs in the Reykjavik capital area of Iceland (2009, 2012-2018). H. influenzae isolated from clinical samples from the middle ear (ME), lower respiratory tract (LRT) (2012-2018) and invasive infections (1996-2018) sent to the Department of Clinical Microbiology were also included in this study. PCR was used for H. influenzae identification with hpd primers, and fucK primers for hpd-negative isolates. bexA primers were used for capsule detection, then further serotyped with serotype specific primers. Disk diffusion and E-tests were used to test for antibiotic susceptibility. The screening test from The Nordic Committee on Antimicrobial Susceptibility Testing was used for detection of β-lactam resistance mechanism(s), using benzylpenicillin unit 1 ...
format Thesis
genre Iceland
genre_facet Iceland
id ftskemman:oai:skemman.is:1946/33427
institution Open Polar
language English
op_collection_id ftskemman
op_relation http://hdl.handle.net/1946/33427
publishDate 2019
record_format openpolar
spelling ftskemman:oai:skemman.is:1946/33427 2025-01-16T22:34:57+00:00 The epidemiology of Haemophilus influenzae in healthy carriers and infected in Iceland following the introduction of Protein D conjugated vaccine Faraldsfræði Haemophilus influenzae úr heilbrigðum og sýktum á Íslandi í kjölfar bólusetningar með prótein D tengdu bóluefni Sandra Berglind Tómasdóttir 1994- Háskóli Íslands 2019-06 application/pdf http://hdl.handle.net/1946/33427 en eng http://hdl.handle.net/1946/33427 Lífeindafræði Bakteríusjúkdómar Sýkingar Ónæmisfræði Bólusetningar Thesis Master's 2019 ftskemman 2022-12-11T06:55:18Z Introduction: Haemophilus influenzae is part of the normal flora of the nasopharynx but can cause a variety of infections, especially in young children and patients with underlying diseases. H. influenzae can express a polysaccharide capsule, six serotypes (a-f) have been identified. Strains without a capsule are called Non-Typeable H. influenzae (NTHi). Antibiotic resistance in H. influenzae has increased for the last decade, especially because of penicillin-binding protein 3 (PBP3) modifications. In 2011 a 10-valent conjugated pneumococcal vaccine (PHiD-CV) was introduced in Iceland, which uses protein D (PD) derived from NTHi as a conjugate. PD is encoded by the hpd gene and is in most H. influenzae. By using PD as a conjugate there is a possibility that the vaccine could provide protection against H. influenzae infections. Aims: The aims of this study were to continue to assess the effects of the vaccination on carriage rate of H. influenzae among healthy children, the prevalence of the hpd gene and each serotype of H. influenzae both in carriage isolates and in clinical samples. Furthermore, to assess the effects on the antimicrobial susceptibility pattern of H. influenzae. Material and methods: Nasopharyngeal samples were obtained from healthy children attending 15 DCCs in the Reykjavik capital area of Iceland (2009, 2012-2018). H. influenzae isolated from clinical samples from the middle ear (ME), lower respiratory tract (LRT) (2012-2018) and invasive infections (1996-2018) sent to the Department of Clinical Microbiology were also included in this study. PCR was used for H. influenzae identification with hpd primers, and fucK primers for hpd-negative isolates. bexA primers were used for capsule detection, then further serotyped with serotype specific primers. Disk diffusion and E-tests were used to test for antibiotic susceptibility. The screening test from The Nordic Committee on Antimicrobial Susceptibility Testing was used for detection of β-lactam resistance mechanism(s), using benzylpenicillin unit 1 ... Thesis Iceland Skemman (Iceland)
spellingShingle Lífeindafræði
Bakteríusjúkdómar
Sýkingar
Ónæmisfræði
Bólusetningar
Sandra Berglind Tómasdóttir 1994-
The epidemiology of Haemophilus influenzae in healthy carriers and infected in Iceland following the introduction of Protein D conjugated vaccine
title The epidemiology of Haemophilus influenzae in healthy carriers and infected in Iceland following the introduction of Protein D conjugated vaccine
title_full The epidemiology of Haemophilus influenzae in healthy carriers and infected in Iceland following the introduction of Protein D conjugated vaccine
title_fullStr The epidemiology of Haemophilus influenzae in healthy carriers and infected in Iceland following the introduction of Protein D conjugated vaccine
title_full_unstemmed The epidemiology of Haemophilus influenzae in healthy carriers and infected in Iceland following the introduction of Protein D conjugated vaccine
title_short The epidemiology of Haemophilus influenzae in healthy carriers and infected in Iceland following the introduction of Protein D conjugated vaccine
title_sort epidemiology of haemophilus influenzae in healthy carriers and infected in iceland following the introduction of protein d conjugated vaccine
topic Lífeindafræði
Bakteríusjúkdómar
Sýkingar
Ónæmisfræði
Bólusetningar
topic_facet Lífeindafræði
Bakteríusjúkdómar
Sýkingar
Ónæmisfræði
Bólusetningar
url http://hdl.handle.net/1946/33427